About US
Contact us
-
Sun Pharmaceutical agrees to acquire Japan’s Pola PharmaIndia-based drugmaker Sun Pharmaceutical Industries has signed a definitive agreement to acquire Pola Pharma, a Japan-based pharma firm involved in theresearch, development, manufacture, and sale of b2018/11/29
-
EC approves Sandoz’s biosimilar Ziextenzo for febrile neutropeniaNovartis unitSandozhas received marketing authorisation from the European Commission (EC) for biosimilar Ziextenzo (pegfilgrastim). Ziextenzo is intended to cut down the duration of neutropenia and i2018/11/29
-
FDA grants ODD for AstraZeneca’s Fasenra to treat EGPAThe US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for AstraZeneca’s Fasenra (benralizumab) to treat eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoi2018/11/28
-
Nuformix expands licensing agreement with NSB for NXP001Nuformix has expanded its licensing agreement with its Chinese licensing partner Newsummit Biopharma (NSB) for NXP001, which is being developed for cancer supportive care. In order to further validat2018/11/28
-
EC approves Mundipharma’s Pelmeg to treat febrile neutropeniaThe Mundipharma network of independent associated companies has received European Commission (EC) approval for the use of Pelmeg (pegfilgrastim) for treatment of febrile neutropenia in adult cancer pa2018/11/27
-
Fluidic Analytics gains funding for lab-tools products launchUK-based Fluidic Analytics has raised $31m in the latest round of financing led by European venture capital fund Draper Esprit. Other major investors include IQ Capital, Delin Ventures, the Business2018/11/27
-
FDA approves Pfizer’s Daurismo to treat acute myeloid leukaemiaThe US Food and Drug Administration (FDA) has approved Pfizer’s Daurismo (glasdegib) indication to treat patients with newly diagnosed acute myeloid leukaemia (AML). The once-daily oral medicine is t2018/11/26
-
EU approves Camurus’s Buvidal injections to treat opoid dependencySwedish research-based pharmaceutical and biotechnology company Camurus has received European Commission (EC) approval for weekly and monthly Buvidal injections to treat opioid dependency in adults an2018/11/26
-
Moments matter in Pfizer and Bristol-Myers Squibb's latest pitch for afib awarenessPfizer and Bristol-Myers Squibb are taking on atrial fibrillationagain with a newawareness campaign. Called “Matter of Moments,” the multichannel effort looks to raise awareness about the connection b2018/11/23
-
Mylan West Virginia plant tagged with warning letter by FDAThe other shoe has finally dropped on Mylan’s troubled manufacturing plant in West Virginia. The drugmaker acknowledged Tuesday that the FDA this month issued a warning letter for the problems at the2018/11/23